Home » Emerging technologies » News digest #256 – The Internet of synthetic biology things + measuring what matters + GreenLight Biosciences announces $50M

News digest #256 – The Internet of synthetic biology things + measuring what matters + GreenLight Biosciences announces $50M

SynBioBeta Digest

News, trends, and stories from the synthetic biology industry

Hi %%first_name%%,

In our quest to make biology easier to engineer, one thing that continues to be of utmost importance is our ability to measure biology accurately. Recently we spoke with Darlene Solomon, CTO of Agilent, about how hardware platforms, IoT, and government initiatives are enabling accurate and sensitive biological measurements — and where we have room to grow. 

Darlene Solomon, CTO of Agilent.

Measuring what matters counts, but how we share what we measure counts, too. In a feature guest blog, Marc Salit, who leads the Genome-Scale Measurements Group at the US National Institute of Standards and Technology, discusses how we can rethink how we share data to turn synthetic biology projects from terrariums into thriving ecosystems that have broken beyond glass walls. 

As synthetic biology evolves into a fully-fledged engineering discipline, it must tackle current inconsistencies in measurements and enhance the reproducibility of experiments. Fortunately, companies are devising and implementing new tools to make biology simpler to understand. Learn how the Internet of Things could help synthetic biology in its quest towards standardization. 

Before synthetic biology can retool the economy, save the planet, or help put people on Mars, it’s going to have to become significantly easier to use. Arbor Biosciences is working to change that by making many of the traditional methods obsolete. “With rapid cell-free expression, more proteins can be designed, produced, and investigated for diverse applications,” says Matthew Hymes, marketing director at Arbor Biosciences. Arbor has just been acquired by Chiral Technologies. 

“There is a great synergy between these two revolutionary technologies in synthetic biology,” says Evelyn Eggenstein, product development scientist at Arbor Biosciences, speaking of Arbor’s collaboration with Labctye.

If you missed the launch of our new 2019 venue, then check out the website here and use code “welcomehome” for a discount. I’ll be speaking at the Impact.tech Seminar: “Introduction to Synthetic Biology” on Jan 24th, 2019 in San Francisco, click here to apply to attend.

Have a great week!

Latest news

GreenLight Biosciences announces $50 million funding round

Read more →

Sigilon Therapeutics and MIT to advance programmable living therapeutics

Read more →

Vertex and Arbor Biotechnologies to discover proteins to advance gene-editing therapies 

Read more →

AmpliPhi Biosciences and C3J Therapeutics agree to merge

Read more →

Sana Biotechnology launches focusing on engineering cells to create medicines

Read more →

Locus Biosciences and J&J Innovation to develop CRISPR-Cas3 Therapeutics

Read more →

More reads

More reads

Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments (Xconomy)

US requires labeling of GMO foods as “bioengineered” (C&EN)

Syntheseas to apply precision breeding and new gene editing technologies to improve aquaculture (Los Angeles Business Journal)

As market shifts, Atlas Venture closes a $250 million fund to support its breakaway biotech bets (Tech Crunch)

Beyond Translation: the Venture-focused research institute (Deep Science Ventures) 

Berkeley Lights announces collaboration with University of Pennsylvania to advance CAR-T therapeutics (Press release)

CRISPR might soon create spicy tomatoes by switching on their chili genes (MIT Tech Review)

A collaborative effort to boost EU synthetic biology competitiveness (Press release)

Stamp of approval for algae-based synthetic biology (Manufacturing Chemist)

Finding the right balance: digital biology versus smart, transformative automation (Solentim)

Synlogic progresses clinical and preclinical pipeline and outlines 2019 catalysts (Press release)

Twist Bioscience enhances genes product offering with longer genes and offers access to its application programming interface (Press release)

Who's hiring?

Who’s hiring?

Software Engineer – Back-end: Serotiny

Synthetic Biology Research Associate: LanzaTech

Scientist, Strain Engineering at 64-x

Scientist I, Molecular Diagnostics Platform Innovation: CRISPR diagnostics startup

Careers in Protein Engineering at Codexis

Senior Software Engineer: CATALOG

Head of Bioprocess: C16 Biosciences

Engineering Lead: Ansa Biotechnologies

Scientist, Microorganism Engineering at 64-x

Scientist: CATALOG

Mammalian Synthetic Biology – Protein Engineer: Serotiny

Mechanical Engineer: CATALOG

Synthetic and Microbial Biologist: C16 Biosciences

Feature your job here →


Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks